Codexis (CDXS) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.35% |
| Dec 31, 2025 | 72.93% |
| Sep 30, 2025 | -17.26% |
| Jun 30, 2025 | -12.27% |
| Mar 31, 2025 | -57.47% |
| Dec 31, 2024 | -35.09% |
| Sep 30, 2024 | -67.33% |
| Jun 30, 2024 | -19.19% |
| Mar 31, 2024 | -22.26% |
| Dec 31, 2023 | -72.63% |
| Sep 30, 2023 | -67.59% |
| Jun 30, 2023 | -15.12% |
| Mar 31, 2023 | -17.09% |
| Dec 31, 2022 | -8.40% |
| Sep 30, 2022 | 43.42% |
| Jun 30, 2022 | 22.82% |
| Mar 31, 2022 | -25.69% |
| Dec 31, 2021 | -33.73% |
| Sep 30, 2021 | 51.57% |
| Jun 30, 2021 | -203.90% |
| Mar 31, 2021 | -99.25% |
| Dec 31, 2020 | -17.17% |
| Sep 30, 2020 | -58.68% |
| Jun 30, 2020 | -19.28% |
| Mar 31, 2020 | 18.02% |
| Dec 31, 2019 | -22.30% |
| Sep 30, 2019 | -20.94% |
| Jun 30, 2019 | -5.15% |
| Mar 31, 2019 | -3.46% |
| Dec 31, 2018 | 28.69% |
| Sep 30, 2018 | 32.08% |
| Jun 30, 2018 | -2.38% |
| Mar 31, 2018 | -3.72% |
| Dec 31, 2017 | 29.27% |
| Sep 30, 2017 | -4.66% |
| Jun 30, 2017 | -15.44% |
| Mar 31, 2017 | -51.62% |
| Dec 31, 2016 | 30.49% |
| Sep 30, 2016 | -35.83% |
| Jun 30, 2016 | 66.54% |
| Mar 31, 2016 | -50.39% |
| Dec 31, 2015 | 88.21% |
| Sep 30, 2015 | -30.52% |